lomustine has been researched along with fluorodeoxyglucose f18 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Broome, J; du Plessis, DG; Fildes, D; Haylock, B; Husband, D; Jenkinson, MD; Joyce, KA; Kopitzki, K; Prosser, J; Smith, T; Vinjamuri, S; Walker, C; Warnke, PC | 1 |
| Bouttens, F; D'Haene, N; Du Four, S; Duerinck, J; Everaert, H; Le Mercier, M; Michotte, A; Neyns, B; Salmon, I; Van Binst, AM; Vandervorst, F; Verschaeve, V | 1 |
1 trial(s) available for lomustine and fluorodeoxyglucose f18
| Article | Year |
|---|---|
Randomized phase II study of axitinib versus physicians best alternative choice of therapy in patients with recurrent glioblastoma.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antineoplastic Agents, Alkylating; Axitinib; Bevacizumab; Brain Neoplasms; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Imidazoles; Indazoles; Lomustine; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Radiopharmaceuticals; Steroids; Treatment Outcome; Young Adult | 2016 |
1 other study(ies) available for lomustine and fluorodeoxyglucose f18
| Article | Year |
|---|---|
Genetic and metabolic predictors of chemosensitivity in oligodendroglial neoplasms.
Topics: Adult; Aged; Alleles; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 19; Disease Progression; Female; Fluorodeoxyglucose F18; Genetic Predisposition to Disease; Genotype; Humans; Lomustine; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Oligodendroglioma; Procarbazine; Prospective Studies; Survival Rate; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2006 |